K. Halka

发表

A Case of Acquired Hemophilia A in a Patient with Exposure to COVID-19

Jorge D. Guerra, Jasmine Gowarty, Jordan Buess, 2022, Case reports in hematology.

Newly diagnosed congenital factor VII deficiency and utilization of recombinant activated factor VII (NovoSeven®)

C. Cable, K. Halka, Nicole S Bartosh, 2013, Clinical pharmacology : advances and applications.

Eculizumab safely reverses neurologic impairment and eliminates need for dialysis in severe atypical hemolytic uremic syndrome

M. Ohanian, C. Cable, K. Halka, 2011, Clinical pharmacology : advances and applications.

Leptomeningeal myelomatosis in previously treated high-risk kappa light chain multiple myeloma: case report and literature review

J. Alaly, M. Ohanian, C. Cable, 2011 .

Long-term marrow cultures from mice with busulfan-induced chronic latent aplasia.

J. Caro, A. Erslev, K. Halka, 1987, The Journal of laboratory and clinical medicine.

A rare restriction enzyme site polymorphism in the breakpoint cluster region (bcr) of chromosome 22.

P. Gascón, A. Grossman, P. Benn, 1988, Leukemia.

Reduced dose maintenance eculizumab in atypical hemolytic uremic syndrome (aHUS): an update on a previous case report

M. Ohanian, C. Cable, K. Halka, 2011, Clinical pharmacology : advances and applications.

Long-term safety and efficacy of factor IX gene therapy in hemophilia B.

Michael Recht, Pratima Chowdary, Deepak Raj, 2014, The New England journal of medicine.

Adeno-Associated Mediated Gene Transfer for Hemophilia B:8 Year Follow up and Impact of Removing "Empty Viral Particles" on Safety and Efficacy of Gene Transfer

A. Nienhuis, C. Morton, A. Davidoff, 2018, Blood.

Granulopoiesis in long-term culture by marrow from mice with busulfan-induced chronic latent aplasia.

J. Caro, A. Erslev, K. Halka, 1986, International journal of cell cloning.

Potentiation of renal tumorigenicity by cyclosporine A in streptozotocin diabetic rats.

A. Reddi, G. Jyothirmayi, M. Y. Khan, 1991, Cancer letters.

Melflufen Therapy for Relapsed Refractory Multiple Myeloma (RRMM) Patients Refractory to Daratumumab and/or Pomalidomide: A Report on Early Efficacy

P. Richardson, A. Oriol, A. Larocca, 2017 .

A randomized, multicenter, phase (Ph) III study comparing carfilzomib (CFZ), lenalidomide (LEN), and dexamethasone (Dex) to LEN and Dex in patients (Pts) with relapsed multiple myeloma (MM).

A. Jakubowiak, D. Siegel, P. Moreau, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Long-term safety and efficacy of factor IX gene therapy in hemophilia B.

M. Kay, A. Nienhuis, J. Gray, 2014, The New England journal of medicine.